January 10, 2020
Bukwang Pharmaceutical Co., Ltd. (Bukwang) announced that JM-010 has been administered to the first patient in phase 2 s...
January 2, 2020
Bukwang Pharmaceutical announced that it has entered into an agreement with Sanofi-Aventis Korea to co-promote an ARB cl...
November 13, 2019
ProteKt Therapeutics, a biotech company developing new PKR kinase inhibitor based therapies for neurodegenerative diseas...
September 30, 2019
ASLAN spins out pre-clinical assets in joint venture with Bukwang to form JAGUAHR Therapeutics with Bukwang investing up...
July 25, 2019
Dr Jean Bousquet, a renowned expert in pulmonary allergy, has delivered a keynote lecture on the next generation guideli...
July 10, 2019
3 million dollars invested by Medici Investment
European Clinical phase 2 study of JM-010 to treat dyskinesia i...
July 5, 2019
The sales of Dexid for diabetic polyneuropathy, Legalon for liver disease, and Entecavir for chronic hepatitis B are boo...
July 3, 2019
The University of Dundee‘s Drug Discovery Unit (DDU) has announced a multi-million-pound partnership with Korean-based B...
July 1, 2019
Bukwang’s successful launch of Neomed toothpaste on home-shopping marked its expansion on OTC business.
June 28, 2019
BNO BIO has invested $1 million in Nucleix, an Israeli bio-venture
The first global investment by BNO BIO since...
Older Posts >
Bukwang initiates dosing of JM-010 in Europe phase 2 study
Bukwang Pharmaceutical has entered into co-promotion agreement with Sanofi- Aventis Korea on AprovelⓇ product family
ProteKt Therapeutics Raises $3.6 Million in Post-incubation Financing
ASLAN PHARMACEUTICALS AND BUKWANG PHARMACEUTICAL ESTABLISH A JOINT VENTURE, JAGUAHR THERAPEUTICS, TO DEVELOP NOVEL IMMUNO-ONCOLOGY THERAPIES
Bukwang Pharmaceutical hosted a keynote lecture by a renowned expert in pulmonary allergy
Contera Pharma, a subsidiary of Bukwang Pharmaceutical, attracts investment from Medici Investment
Bukwang’s representative ethical products outperformed
University of Dundee partners with Bukwang Pharmaceutical Company to tackle new drug treatment for Parkinson’s disease.
Bukwang successfully launched Neomed toothpaste on home-shopping network
BNO BIO, a joint company by Bukwang and OCI, invests in a bio-venture that develop a technology in early detection of cancer